Ditan
Overview[edit]
Lasmiditan is a medication used for the acute treatment of migraines with or without aura in adults. It belongs to a class of drugs known as serotonin receptor agonists, specifically targeting the 5-HT1F receptor. Unlike other migraine medications, lasmiditan does not cause vasoconstriction, making it a suitable option for patients with cardiovascular risk factors.
Mechanism of Action[edit]
Lasmiditan is a selective agonist of the 5-HT1F receptor, which is a subtype of the serotonin receptor. By activating this receptor, lasmiditan helps to inhibit the release of pro-inflammatory neuropeptides and reduce the transmission of pain signals in the trigeminal system. This action helps alleviate the symptoms of a migraine attack.
Pharmacokinetics[edit]
Lasmiditan is administered orally and is rapidly absorbed, with peak plasma concentrations occurring approximately 1.8 hours after dosing. It is metabolized primarily by non-CYP enzymes and is excreted mainly in the urine. The half-life of lasmiditan is approximately 5.7 hours, allowing for effective relief of migraine symptoms.
Clinical Use[edit]
Lasmiditan is indicated for the acute treatment of migraine attacks. It is not intended for the preventive treatment of migraines. Patients are advised to take lasmiditan as soon as possible after the onset of migraine symptoms. The recommended dose is 50 mg, 100 mg, or 200 mg, depending on the severity of the migraine and the patient's response to the medication.
Side Effects[edit]
Common side effects of lasmiditan include dizziness, fatigue, paresthesia, and somnolence. Due to its central nervous system effects, patients are advised not to drive or operate heavy machinery for at least 8 hours after taking lasmiditan.
Contraindications[edit]
Lasmiditan is contraindicated in patients with hypersensitivity to the drug or any of its components. Caution is advised in patients with severe hepatic impairment, as the pharmacokinetics of lasmiditan may be altered.
Related Pages[edit]
Gallery[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
